Abstract
The role of adjuvant and palliative chemo- and radiotherapy in the treatment of intrahepatic cholangiocarcinoma (ICC) is controversial. There are no prospective and randomised studies or large series that provide conclusive indications regarding the efficacy of these therapies in ICC. Moreover, the majority of oncologic papers in the literature that address this topic include intrahepatic and extrahepatic (hilar, middle and distal) cancers and even gallbladder carcinoma. Consequently, specific data for each localisation concerning treatment indication, dosage, type of approach and results are lacking.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Jan YY, Yeh CN, Yeh TS, Chen TC (2005) Prognostic analysis of surgical treatment of peripheral cholangiocarcinoma: two decades of experience at Chang Grung Memorial Hospital. World J Gastroenterol 11 (12):1779–1784
Asakura H, Ohtsuka M, Ito H et al (2005) Long-term survival after extended surgical resection of intrahepatic cholangiocarcinoma with extensive lymph-node metastasis. Hepatogastroenterology 52 (63):722–724
Puhalla H, Schuell B, Pokorny H et al (2005) Treatment and outcome of intrahepatic cholangiocellular carcinoma. Am J Surg 189 (2):173–177
Miwa S, Miyagawa S, Kobayashi A et al (2006) Predictive factors for intrahepatic cholangiocarcinoma recurrence in the liver following surgery. J Gastroenterol 41 (9):893–900
Fu XH, Tang ZH, Zong M et al (2004) Clinicopathologic features, diagnosis and surgical treatment of intrahepatic cholangiocarcinoma in 104 patients. Hepatobiliary Pancreat Dis Int 3 (2):279–283
Knox JJ, Hedley D, Oza A et al (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol 23 (10):2332–2338
Thongprasert S (2005) The role of chemotherapy in cholangiocarcinoma. Ann Oncol 16 (Suppl 2):ii93–ii96
Kelley ST, Bloomston M, Serafini F et al (2004) Cholangiocarcinoma: advocate an aggressive operative approach with adjuvant chemotherapy. Am Surg 70 (9):743–748; discussion 748–749
Khan SA, Davidson BR, Goldin R et al; British Society of Gastroenterology (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51 (Suppl 6):VI1–VI9
Casavilla FA, Marsh JW, Iwatsuki S et al (1997) Hepatic resection and transplantation for peripheral cholangiocarcinoma. J Am Coll Surg 185 (5):429–436
Tanaka N, Yamakado K, Nakatsuka A et al (2002) Arterial chemoinfusion therapy through an implanted port system for patients with unresectable intrahepatic cholangiocarcinoma-initial experience. Eur J Radiol 41 (1):42–48
Valverde A, Bonhomme N, Farges O et al (1999) J Hepatobiliary Pancreat Surg 6 (2):122–127
Zeng ZC, Tang ZY, Fan J et al (2006) Consideration of the role of radiotherapy for unresectable intrahepatic cholangiocarcinoma: a retrospective analysis of 75 patients. Cancer J 12 (2):113–122
Higuchi R, Yamamoto M, Hatori T et al (2006) Intrahepatic cholangiocarcinoma with lymph-node metastasis successfully treated by immunotherapy with CD3-activated T cells and dendritic cells after surgery: report of a case. Surg Today 36 (6):559–562
Zgodzinski W, Espat NJ (2005) Radiofrequency ablation for incidentally identified primary intrahepatic cholangiocarcinoma. World J Gastroenterol 11 (33):5239–5240
Chiou YY, Hwang JI, Chou YH et al (2005) Percutaneous ultrasound-guided radiofrequency ablation of intrahepatic cholangiocarcinoma. Kaohsiung J Med Sci 21 (7):304–309
Slakey DP (2002) Radiofrequency ablation of recurrent cholangiocarcinoma. Am Surg 68 (4):395–397
Mazhar D, Stebbing J, Bower M (2006) Chemotherapy for advanced cholangiocarcinoma: what is standard treatment? Future Oncol 2 (4):509–514
Cantore M, Mambrini A, Fiorentini G et al (2005) Phase II study of hepatic intraarterial epirubicin and cisplatin, with systemic 5-fluorouracil in patients with unresectable biliary tract tumours. Cancer 103 (7):1402–1407
Vogl TJ, Schwarz W, Eichler K et al (2006) Hepatic intraarterial chemotherapy with gemcitabine in patients with unresectable cholangiocarcinomas and liver metastases of pancreatic cancer: a clinical study on maximum tolerable dose and treatment efficacy. J Cancer Res Clin Oncol 132 (11):745–755
Mambrini A, Guglielmi A, Pacetti P et al (2007) Capecitabine plus hepatic intraarterial epirubicin and cisplatin in unresectable biliary cancer: a phase II study. Anticancer Res (in press)
Huang TW, Wang CH, Hsieh CB (2007) Effects of the anti-epidermal growth factor receptor antibody cetuximab on cholangiocarcinoma of the liver. Onkologie 30 (3):129–131
Sprinzl MF, Schimanski CC, Moehler M et al (2006) Gemcitabine in combination with EGF-Receptor antibody (Cetuximab) as a treatment of cholangiocarcinoma: a case report. BMC Cancer 6:190
Kirchhoff T, Zender L, Merkesdal S et al (2005) Initial experience from a combination of systemic and regional chemotherapy in the treatment of patients with nonresectable cholangiocellular carcinoma in the liver. World J Gastroenterol 11 (8):1091–1095
Burger I, Hong K, Schulick R et al (2005) Transcatheter arterial chemoembolization in unresectable cholangiocarcinoma: initial experience in a single institution. J Vasc Interv Radiol 16 (3):353–361
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer
About this chapter
Cite this chapter
Guglielmi, A., Ruzzenente, A., Iacono, C. (2008). Adjuvant and Palliative Treatments. In: Surgical Treatment of Hilar and Intrahepatic Cholangiocarcinoma. Updates in Surgery. Springer, Milano. https://doi.org/10.1007/978-88-470-0729-1_23
Download citation
DOI: https://doi.org/10.1007/978-88-470-0729-1_23
Published:
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-0728-4
Online ISBN: 978-88-470-0729-1
eBook Packages: MedicineMedicine (R0)